Found 63 matching trials
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer PHASE1 The purpose of this study is to observe and preliminary explore the efficac...
Show More Location
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Learn More & Join Trial
A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC PHASE2 This an open-label,Non-Randominzed Phase 2 study to evaluate the Safety and...
Show More Location
The Second Affiliated Hospital Of Anhui Medical University
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS PHASE2 This study is a Single-arm, Open, Prospective, Single-center, Phase Ⅱ Clini...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell PHASE3 The purpose of this study is to observe and evaluate the efficacy and safet...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy(Irinotecan Plus Platinum)and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer(SCLC) PHASE2 This single arm, open label, single center, prospective study was designed ...
Show More Location
Beijing Union Medical College Hospital
Learn More & Join Trial
Neoadjuvant Immunotherapy for Resectable Gastric Cancer PHASE2 1. Target population: patients with resectable locally advanced gastric can...
Show More Location
Qilu hospital of Shandong univertisy
Learn More & Join Trial
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC PHASE1 The aim of this study was to investigate the safety and efficacy of SHR-121...
Show More Location
Sichuan Cancer Hospital
Learn More & Join Trial
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC PHASE1 The study is being conducted to evaluate the tolerability, safety and effic...
Show More Location
Beijing Cancer Hosptial
Learn More & Join Trial
Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer PHASE2 This is a study of Camrelizumab combined with Apatinib versus Apatinib alon...
Show More Location
The Sixth Affiliated hosipital, Sun Yat-Sen University
Learn More & Join Trial